ClinicalTrials.govpublic full text
Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
type 2 diabetes mellitus, obesity, cognitive impairment
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 230370
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.